Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.
BJU International|June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlatesAndrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
The American Journal of Pathology|March 26, 2003
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasisGuangwen Cao, Guang Yang, Terry L Timme, et al.
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
Cell Reports|February 24, 2017
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Theodoros Karantanos, Likun Li, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Likun Li, Guang Yang, et al.
The Oncologist|October 29, 2002
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancerBin S Teh, Estuardo Aguilar-Cordova, Maria T Vlachaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Science Advances|March 1, 2024
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditionsAdam R Wolfe, Tiantian Cui, Sooin Baie, et al.
Pageof 16